Marín Yarí E, Chen Suzie
Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers University, 164 Frelinghuysen Rd., Piscataway, NJ 08854, USA.
J Mol Med (Berl). 2004 Nov;82(11):735-49. doi: 10.1007/s00109-004-0566-8. Epub 2004 Aug 21.
Melanoma is the aberrant proliferation of melanocytes, the cells in the skin responsible for pigment production. In the United States the current lifetime risk of melanoma development is 1 in 57 in males and 1 in 81 in females. In its early stages melanoma can be surgically removed with great success; however, advanced stages of melanoma have a high mortality rate due to the lack of responsiveness to currently available therapies. The development of animal models to be used in the studies of melanoma will provide the means for developing improved and targeted treatments for this disease. This review focuses on the recent report of a mouse melanoma model, TG-3, which has implicated the ectopic expression of the metabotropic glutamate receptor 1 (Grm1), a G protein coupled receptor (GPCR), in melanomagenesis and metastasis. The involvement of other GPCRs in cellular transformation, particularly GPCRs in melanoma biology, and signaling of Grm1 are also discussed.
黑色素瘤是黑素细胞的异常增殖,黑素细胞是皮肤中负责产生色素的细胞。在美国,目前男性患黑色素瘤的终生风险为1/57,女性为1/81。在早期阶段,黑色素瘤可以通过手术成功切除;然而,由于对现有疗法缺乏反应,晚期黑色素瘤的死亡率很高。用于黑色素瘤研究的动物模型的开发将为开发针对该疾病的改进型靶向治疗提供手段。本综述重点关注一种小鼠黑色素瘤模型TG-3的最新报告,该模型表明代谢型谷氨酸受体1(Grm1,一种G蛋白偶联受体(GPCR))的异位表达与黑色素瘤的发生和转移有关。还讨论了其他GPCR在细胞转化中的作用,特别是在黑色素瘤生物学中的GPCR,以及Grm1的信号传导。